Phase 2 Colorectal Cancer Trial, Recruiting NCT06793137 Sponsor: AC Camargo Cancer Center Condition: Colorectal Cancer
Back to Colorectal Cancer

Phase 2 Colorectal Cancer Trial, Recruiting

NCT06793137
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older and have been diagnosed with a type of rectal cancer called adenocarcinoma, located in the middle or lower part of the rectum
  • Your cancer is either at an advanced local stage, or its position in the rectum means that surgery to remove the rectum and anus (called rectal amputation) is needed
  • Scans (MRI) show your tumor is located below a certain internal boundary in the rectum, which defines it as being in the middle or lower rectum
  • The lower edge of your tumor is less than 2 cm from a specific internal landmark (the pectineal line or anorectal ring), as measured by a camera examination of the rectum, physical examination, or MRI scan
  • If you have middle rectum cancer, you may be included if your tumor has grown into or very close to the surrounding tissue layer (mesorectal fascia), or if your cancer is classified as a more advanced stage (cT4)

Who may not be able to join:

  • Your overall health and fitness level means you are not well enough to tolerate the full course of treatment planned before surgery (called total neoadjuvant treatment)
  • Your rectal cancer is a type other than adenocarcinoma
  • Your adenocarcinoma has a specific genetic feature called microsatellite instability, which is identified through a laboratory test on your tumor tissue
  • You have a middle rectum tumor that does not meet the specific criteria for receiving radiotherapy before surgery, based on how far it has spread and whether the surrounding tissue layer appears clear of cancer on scans (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Samuel Aguiar Jr, MD, PhD, A.C. Camargo Cancer Center

Phone: + 55 (11) 2189-5010

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
AC Camargo Cancer Center
Registry
ClinicalTrials.gov
Start date
22 July 2024
Est. completion
31 October 2025

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Complete clinical response in total neoadjuvant treatment of rectal adenocarcinoma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov